Skip to main content


Fig. 2 | BMC Cancer

Fig. 2

From: 18F-fluoride positron emission tomography/computed tomography and bone scintigraphy for diagnosis of bone metastases in newly diagnosed, high-risk prostate cancer patients: study protocol for a multicentre, diagnostic test accuracy study

Fig. 2

Pre- and post-androgen deprivation therapy images from planar bone scintigraphy (anterior view). Anterior images from planar bone scintigraphy of one patient at baseline (a) and after 6 months of satisfactory androgen therapy (b). PSA decreased from 92 ng/mL at baseline to 8.8 ng/mL (90 % reduction), and plasma-testosterone decreased from 1.7 to 0.07 ng/ml. All lesions initially suspected of malignancy in the axial skeleton demonstrated partial or complete regression, whereas lesions in large joints and small joints in the hands and feet were stable or progressed. The activity in the left elbow region is an artifact caused by contamination at tracer injection

Back to article page